CTE cannot currently be diagnosed in living individuals. Tau biomarkers that work for Alzheimer’s don’t detect the tau buildup in CTE because of differences in shape and location. Researchers are working to develop blood and imaging biomarkers that may detect CTE in living individuals in the future.